Authors

Dr Paul England

Senior Counsel – Knowledge

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Verena Bertram

Salary Partner

Read More
Authors

Dr Paul England

Senior Counsel – Knowledge

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Verena Bertram

Salary Partner

Read More

19 December 2019

Synapse - December 2019

This month on Synapse

The 2020s: Boris Johnson's decade to prove his life sciences plan

Paul England discusses what the impact of the Conservative Party election victory may be for the life sciences sector.

No automatic compensation for a wrongful PI, rules the CJEU

Judith Krens and Emma Jansen explain guidance given by the Court of Justice of the European Union in case C-688/17 on the compensation parties can receive when a patent holder has enforced a preliminary injunction against them that is later revoked.

SPC manufacturing waiver (Part 2): The fairy tale of day-1 entry under the manufacturing and stockpiling waiver – a German view

Anja Lunze and Verena Bertram ask whether the new SPC manufacturing waiver offers enough to privilege the manufacture and storage of a corresponding product in the EU in the six months preceding the expiry of the SPC to achieve a day-1 entry.

AI + data = drug discovery

Paul England asks what impact we should expect to see on drug innovation from the combination of sophisticated algorithms and huge amounts of data.

Patents diary: December 2019

In this month's patents diary, Paul England describes English cases concerning jurisdiction for a patent licence dispute and the identity of the skilled person.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Cannabis: what's new for the 6000 year old medicine?

8 November 2018

by Dr Paul England

Click here to find out more
Patents & innovation

Synapse - law for life sciences - May 2018

1 June 2018

by Dr Paul England and Rhys Bufton

Click here to find out more